ACC Conference Wrap-up: Thromboembolic Disease Highlights
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify M…
This cohort study investigates the cardiovascular disease associations and genetic determinants of epicardial and pericardial adiposity.
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of…
Join us as we delve into important trials discussed at ACC 24, in this episode the DanGer Shock Trial.Discover the latest insights, implications, and potenti…
This cohort study uses data from 3 populations to assess whether lipoprotein(a) levels are associated with cardiovascular risk independent of high-sensitivity C-reactive protein level.
Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia. The approval is based on the results…
ATLANTA — A home-based exercise intervention with protein supplementation improved physical performance at 12 weeks for older patients with frailty who underwent transcatheter aortic valve…
New online learning is now freely available about critical appraisal of rapid reviews as part of Cochrane’s flagship Evidence Essentials modules for the public.
ESC official website: Register for ESC Congress and take advantage of the best rates by registering early. The world’s largest conference in cardiovascular medicine, providing…
This is the recording of a lecture delivered to the National Breast Cancer Coalition (NBCC), a patient advocacy group focused on empowering patients with bre…
Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.Â